Annabelle Gérard is a cellular and molecular biologist with close to 20 years of experience. She turned technology developer for almost 10 years. She joined HiFiBiO in 2013 as first employee, and since then led the single cell screening platform for high precision and accuracy T and B cells screening and recovery, both from a phenotypic and Omics angle. As Senior Director of External Innovation at HiFiBiO she led the partnership programs with KOLs in top academic institutions, as well as biotech and big Pharma companies. She is co-inventor of more than 10 patent applications covering methods, instruments and applications in engineering, cellular and molecular biology. She defended her PhD 15 years ago from the Université Pierre et Marie Curie (Paris, France) and completed a post-doctoral research in infectious disease at the Cochin Institute, Paris, France.